"Double chin got you down Theres now a shot for that. The Food and Drug Administration on Wednesday approved  http new treatment for adults with moderatetosevere fat below the chin known as submental fat. The drug Kybella is a form of synthetically derived deoxycholic acid which the body produces naturally to help absorb fats. Kybella is aimed at destroying fat cells when injected in the area below the chin while leaving surrounding tissue essentially unaffected. The FDA warned however that the treatment also has the potential to kill other types of cells such as skin cells if injected improperly. Patients can receive as many as  injections of the drug in a single treatment the agency said with up to six treatments administered no less than a month apart. That might seem like a lot of pain for the pleasure of a slimmeddown chin but currently patients looking to part with their double chins must have fat removed through more invasive means such as liposuction. More women want big butts and the stats dont lie http The market for the new drug could be a big one. According to a survey  https year by the American Society for Dermatologic Surgery nearly  percent of respondents listed excess fat under the chinneck as a key concern about their appearance. And Americans repeatedly have demonstrated a willingness to shell out money for aesthetic treatments intended to improve their appearance if not their overall health. A top example Annual sales of the antiwrinkle drug Botox have surged  http  billion in recent years. Keith Leonard chief executive of Kythera the Californiabased firm that developed Kybella said at a conference last month that he believes the new treatment can drive a very large market and leave very satisfied patients. The FDA said Kybella demonstrated safety and efficacy in two clinical trials involving more than  adults. A reduction in chin fat was observed more frequently in patients receiving the treatment than in those who got a placebo. Seriously why does anyone under  still have access to a tanning bed http That said the agency warned Wednesday that the new drug can cause serious side effects including trouble swallowing or nerve damage to the jaw that can result in an uneven smile or muscle weakness in the face. The most common side effects included swelling bruising pain numbness redness and areas of hardness in the vicinity of the injection. FDA officials said Kybella should be administered only by a licensed health care professional and shouldnt be injected anywhere other than below the chin. A Kythera representative said Wednesday that the new treatment likely wont be available until June as it must train doctors to administer Kybella and that the company would not have more details about the potential cost of the drug until after its launch."